Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 8, 2026, 1:12 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2545–2568 of 3,418 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Routine Clear all

Conditions: Chronic Kidney Disease, Pediatric Urology
Interventions: NSAIDs, Placebo; Drug
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Months to 25 Years
Enrollment: 164 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Hearing Loss, Geriatric Disorder
Interventions: Tele-HS, PCP encouragement; Other
Lead sponsor: Duke University; Other
Eligibility: 65 Years to 75 Years
Enrollment: 1,146 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2021
U.S. locations: 6
States / cities: Ann Arbor, Michigan • New Hyde Park, New York • New York, New York + 3 more

Conditions: Down Syndrome, Obstructive Sleep Apnea
Interventions: Open-ended semi-structured interviews; Behavioral
Lead sponsor: Children's Hospital of Philadelphia; Other
Eligibility: 6 Years to 17 Years
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Diabetes Mellitus, Type 1
Interventions: Diabetes Navigator; Behavioral
Lead sponsor: Johns Hopkins University; Other
Eligibility: 5 Years to 75 Years
Enrollment: 148 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Survivors of Childhood Cancer, Substance Use
Interventions: WHO ASSIST v3.1 Screening with Feedback, ASSIST Linked Brief Intervention (10 Step Motivational interviewing (MI)/FRAMES), WHO ASSIST v3.1 Screening (No Feedback); Behavioral
Lead sponsor: St. Jude Children's Research Hospital; Other
Eligibility: 15 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Memphis, Tennessee

Conditions: Recurrent Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer
Interventions: omega-3 fatty acid supplement, Placebo, Clinical assessments, Assessment of therapy complications, Magnetic Resonance Imaging, Correlative/special studies; Dietary Supplement · Other · Procedure
Lead sponsor: Ohio State University Comprehensive Cancer Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 44 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2014
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Osteonecrosis
Interventions: hyperbaric oxygen, non-treated control group; Device
Lead sponsor: Duke University; Other
Eligibility: Not listed
Enrollment: 54 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2010
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Hearing Loss
Interventions: Clinically Streamlined and Structured Aural Rehabilitation (CSSAR); Behavioral
Lead sponsor: Case Western Reserve University; Other
Eligibility: 55 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Attention Deficit Hyperactivity Disorder, Delayed Sleep Phase Type Circadian Rhythm Sleep Disorder
Interventions: Polarized glasses designed to filter out blue light; Device
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 19 Years and older
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: COVID-19, SARS CoV 2 Infection, COVID-19 Pandemic
Interventions: Lollipop Swab; Diagnostic Test
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 4 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: HIV
Interventions: Monetary Incentive, Questionnaire Timing, HIV Test Offering; Behavioral
Lead sponsor: University of California, San Francisco; Other
Eligibility: 13 Years to 64 Years
Enrollment: 8,572 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2013
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Myelodysplastic Syndrome, Acute Myeloid Leukemia
Interventions: Collection of Leukemia Cells; Other
Lead sponsor: Dana-Farber Cancer Institute; Other
Eligibility: 18 Years and older
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Carcinoma, Renal Cell
Interventions: Sunitinib, Temsirolimus, Sorafenib, Pazopanib, Everolimus, Axitinib; Drug
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 18 Years and older
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Hemophilia A
Interventions: Emicizumab, Factor VIII (FVIII); Drug
Lead sponsor: Hoffmann-La Roche; Industry
Eligibility: 12 Years and older
Enrollment: 152 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2022
U.S. locations: 8
States / cities: Santa Monica, California • Washington D.C., District of Columbia • Gainesville, Florida + 5 more

Conditions: Inflammatory Bowel Diseases, Colo-rectal Cancer
Interventions: no intervention will be given to patients.; Other
Lead sponsor: University of Texas at Austin; Other
Eligibility: 18 Years to 99 Years
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2022
U.S. locations: 1
States / cities: Austin, Texas

Conditions: Lung Cancer
Interventions: Sputum sample, Pulmonary function tests, Computerized tomography (CT) scan of the chest, Buccal epithelium collection, Nasal brushings, Bronchoscopy, Bronchoalveolar lavage, Blood sample collection, Urine sample, Questionnaire-data collection; Procedure · Radiation · Other
Lead sponsor: Vanderbilt-Ingram Cancer Center; Other
Eligibility: 55 Years to 80 Years
Enrollment: 480 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2026
U.S. locations: 2
States / cities: Nashville, Tennessee

Conditions: Validate Volumetric Absorptive Microsampling (VAMS) Assay
Interventions: Mitra Microsampler; Device
Lead sponsor: Children's Hospital Medical Center, Cincinnati; Other
Eligibility: 1 Year to 21 Years
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Triple Negative Breast Cancer, Vitamin D Deficiency, Invasive Breast Cancer
Interventions: Standard of Care Neoadjuvant Chemotherapy (NAC), Vitamin D3, Drug Diary; Drug · Dietary Supplement · Other
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Opioid Use Disorder
Interventions: PROCare; Behavioral
Lead sponsor: Medical Decision Logic, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Cognitive Impairment, Dementia, ADD, Depression
Interventions: Passive testing, Active testing; Diagnostic Test
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2028
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Gestational Diabetes Mellitus
Interventions: Diet, Exercise, and Breastfeeding Intervention; Behavioral
Lead sponsor: Kaiser Permanente; Other
Eligibility: 20 Years to 45 Years · Female only
Enrollment: 180 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2005
U.S. locations: 5
States / cities: Oakland, California • San Francisco, California • Santa Clara, California + 1 more

Conditions: Infectious Disease
Interventions: CareCube; Device
Lead sponsor: Saint Luke's Health System; Other
Eligibility: 18 Years and older
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021
U.S. locations: 1
States / cities: Kansas City, Missouri

Conditions: Autism Spectrum Disorder (ASD), Autism
Interventions: Early Start Denver Model (ESDM), Pivotal Response Treatment (PRT), Developmental Reciprocity Treatment (DRT); Behavioral
Lead sponsor: Stanford University; Other
Eligibility: 2 Years to 4 Years
Enrollment: 140 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2037
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Pulmonary Arterial Hypertension
Interventions: mHealth Intervention, Usual Care; Device
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 10 Years to 21 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2030
U.S. locations: 1
States / cities: Nashville, Tennessee

Search by objective public record fields.

Safety of Short-course of NSAIDs in Pediatric Patients With CKD

Addressing Barriers to Adult Hearing Healthcare

Investigating the Experience of Living With Down Syndrome and Obstructive Sleep Apnea Syndrome (Stage 1)

Assessing Effectiveness of a Diabetes Navigator in Increasing Progression of Advanced Diabetes Technologies

Feasibility of Incorporating a Standardized Substance Use Measure With Linked-Brief Intervention Into Routine Psychosocial Care of Adult Childhood Cancer Survivors

Omega-3 Fatty Acids in Preventing Joint Symptoms in Patients With Stage I-III Breast Cancer Receiving Anastrozole, Exemestane, or Letrozole

Randomized Controlled Trial of Hyperbaric Oxygen in Patients Who Have Taken Bisphosphonates

Benefit of a Clinically Streamlined and Structured Aural Rehabilitation (CSSAR) Program in Adults

Blue Wavelength Light-blocking Glasses in ADHD-Insomnia

Lollipop COVID-19 Testing Study

HIV Screening Take-up: Evaluating Incentives and Opt-out Strategies

Collection and Banking of Leukemia Cells MDS/AML

Personalized Targeted Inhibitors Treatment in Renal Cell Cancer

A Clinical Trial to Evaluate Prophylactic Emicizumab Versus no Prophylaxis in Hemophilia A Participants Without Inhibitors

Collection of Gastrointestinal Malignant and Non-malignant Human Samples

Nashville Early Diagnosis Lung Cancer Project

Tacrolimus Microsampling

Impact of Vitamin D Supplementation on the Rate of Pathologic Complete Response in Vitamin D Deficient Patients

Reward-Based Recovery Outcomes Management for Opioid Use Disorder

Investigating Dynamic Interactions in Distributed Cognitive Control Networks

Diet, Exercise, and Breastfeeding Intervention Program for Women With Gestational Diabetes (DEBI Trial)

Implementation of CareCube Negative Pressure Isolation Units

Trial of Center-Based Early Start Denver Model vs. Pivotal Response Treatment in Children With Autism

Mobile Health Intervention to Improve Exercise in Pediatric PH